Usefulness of bone mineral density measurement in menopausal woman: A study of 217 post menopausal women

Bangladesh Medical Research Council Bulletin

Volumn 30, Issue 1, 2004, Pages 25-30

  Ansari, S M ^a   Begum, T ^a   Siddique, A B ^a  

^a Shaheed Ziaur Rahman Medical College   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CALCIUM; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BONE DENSITY; BONE MINERALIZATION; BONE RADIOGRAPHY; CONTROLLED STUDY; DENSITOMETRY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; EARLY DIAGNOSIS; FEMALE; FEMUR; FRAGILITY FRACTURE; HORMONE SUBSTITUTION; HUMAN; LOW BACK PAIN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; METABOLIC BONE DISEASE; NON INVASIVE MEASUREMENT; OSTEOLYSIS; OSTEOPENIA; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; TREATMENT PLANNING;

BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; FRACTURES, BONE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; POSTMENOPAUSE;

EID: 4143083783     PISSN: 03779238     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Benson R.C, Pernoll M.L. The nonreproductive years. In "Handbook of Obstretics and Gynecology". McGraw Hill Inc. 9th. ed. 1994; 639-48.
2. Utian W.H. The menopause and climacteric. In "Scientific foundation of obstretics and gynecology". Edited by: Philipp E, Setchell M, Ginsberg J. Butteworth- Heinemann Ltd. UK. 1991. 199-207.
3. P.L. Drury, M. Shipley. Rheumatology and bone disease. In " Clinical Medicine". Edited by: P Kumar, M Clark. W.B.Saunders. UK. 1998. 447-518.
4. Riggs B.L, Melton J.L. Involution osteoporosis. New Eng Jour Med. 1986; 314: 1676.
5. Consensus Development Conference: Diagnosis, prophylaxis and treatment of Osteoporosis. Am J Med. 1993; 94: 646-50.
6. Nelson DA, Molloy R, Kleerkoper M. Prevalence of osteoporosis in woman referred for bone density testing: Utility of multiple skeletal sites. J Clin Densitometry. 1998; 1: 5-13.
7. G.Nuki. Diseases of the Connective tissues, joints and bones. In "Davidson's Principles and Practices of Medicine". Edited by. C R W Edwards, I A D Bouchier, C Haslell, E R Chilvers. Churchill - Livingstone Publishers. UK. 1996: 863-940.
8. Fogelman I, Blake G.M. Different approaches to bone densitometry. J Nucl Med. 2000; 41: 2015-25.
9. Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a worldwide projection. Osteoporosis Int. 1992; 2: 285-9.
10. Utian W.H. The menopause and climacteric. In "Scientific foundation of obstretics and gynecology". Edited by: Philipp E, Setchell M, Ginsberg J. Butteworth-Heinemann Ltd. UK. 1991:199-207.
11. Kaplan F.S. Osteoporosis: pathophysiology and prevention. Clinical Symposia. 1987; 39: 1-37.
12. P.L. Drury, M. Shipley. Rheumatology and bone disease. In "Clinical Medicine". Edited by: P Kumar, M Clark. W.B.Saunders. UK. 1998:447-518.
13. Cheng XG, Lowet G, Booner S. Prediction of vertebral and femoral strength in vitro by BMD measured at different skeletal sites. J Bone Min Res. 1998; 13: 1443-39.
14. Cummings SR, Black DM, Nevitt MC. Bone density at various sites for prediction of hip fractures. Lancet. 1993; 341: 72-5.
15. Hosking D, Chilvers CED, Christiansen C. Prevention of bone loss with alendronate in post-menopausal woman under 60 years of age. N Eng J Med. 1998; 338: 485-92.
16. Black BM, Cummings SR, Karpf DB. Randomized trial of the effect of alendronate on fractures in women with pre - existing vertebral fracture: the FIT research group. Lancet. 1996; 348: 1535-41.